Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLAPARIB Cause Wrong technique in product usage process? 19 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Wrong technique in product usage process have been filed in association with OLAPARIB (Lynparza). This represents 0.1% of all adverse event reports for OLAPARIB.

19
Reports of Wrong technique in product usage process with OLAPARIB
0.1%
of all OLAPARIB reports
1
Deaths
5
Hospitalizations

How Dangerous Is Wrong technique in product usage process From OLAPARIB?

Of the 19 reports, 1 (5.3%) resulted in death, 5 (26.3%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does OLAPARIB Cause?

Death (4,378) Malignant neoplasm progression (1,862) Nausea (1,582) Anaemia (1,455) Fatigue (1,437) Off label use (777) Vomiting (642) Drug ineffective (563) Diarrhoea (514) Asthenia (491)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which OLAPARIB Alternatives Have Lower Wrong technique in product usage process Risk?

OLAPARIB vs OLARATUMAB OLAPARIB vs OLECLUMAB OLAPARIB vs OLIVE OIL\SOYBEAN OIL OLAPARIB vs OLMESARTAN OLAPARIB vs OLMESARTAN MEDOXOMIL

Related Pages

OLAPARIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process OLAPARIB Demographics